Assessment of the efficacy of buspirone in patients affected by generalized anxiety disorder, shifting to buspirone from prior treatment with lorazepam: a placebo-controlled, double-blind study.

Chiaie R, Delle; P, Pancheri; M, Casacchia; P, Stratta; GD, Kotzalidis; M, Zibellini

doi:10.1097/00004714-199502000-00003

Public

Assessment of the efficacy of buspirone in patients affected by generalized anxiety disorder, shifting to buspirone from prior treatment with lorazepam: a placebo-controlled, double-blind study.

Shared by NobleBlocks on Feb 1, 1995 • 12:00 AM UTC

Authors:

Delle Chiaie R

Pancheri P

Casacchia M

Abstract

Forty-four patients with DSM-III-R generalized anxiety disorder participated in this double-blind, randomized study. Patients were on a benzodiazepine before the study and were stabilized on 3 to 5 mg/day lorazepam for 5 weeks (weeks 0 to 5). Thereafter, they were randomized to 15 mg/day buspirone o...

Discussions